prana to present at global healthcare conferen, page-9

I also understand that to be true macrae.
The content of Prana's presentation, which I believe is going to be extremely good, at the healthcare conference in Monaco, needs to be supported by the general Stock Market rule of full transparancy. Prana is presenting a Progress Update, not neccessarily of the drug undergoing human trials but of the Company itself, to the Elite of their peers in the Medical profession on 'The World Stage'. This is not just a marketing exercise. There must be something of substance in the presentation, not only to the industry but also to the general public, but in order to do that, they need to announce to the share holders first if the information is market sensitive. Therefore, ann to the market should be released very soon, unless the company rainmaker's strategy is to hold back until a date closer to 4th qtr trial results for maximum impact and to impress big Pharma.